The Rhamnolipids Market size is estimated at USD 41.15 million in 2024, and is expected to reach USD 52.47 million by 2029, growing at a CAGR of 4.98% during the forecast period (2024-2029).
The COVID-19 outbreak resulted in a global lockdown, a breakdown in supply chains and manufacturing activities, and production halts, all of which had a detrimental effect on the market in 2020. However, things started to get better in 2021, which allowed the market to resume its upward trend for the remainder of the projected period.
The global rhamnolipids market is partially consolidated in nature with only few major players dominating the market. Some of the major companies are (not in any particular order) Evonik Industries AG, Jeneil, GlycoSurf, AGAE Technologies, LLC, and Biotensidon GmbH among others.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook